{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Group+2+in+Part+B+and+Part+C", "query": { "intervention": "Group 2 in Part B and Part C" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 106, "total_pages": 11, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Group+2+in+Part+B+and+Part+C&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T12:21:46.406Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04569786", "title": "Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Coronavirus Disease (COVID-19)" ], "interventions": [ { "name": "V590", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 232, "start_date": "2020-10-29", "completion_date": "2021-02-18", "has_results": true, "last_update_posted_date": "2021-12-29", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 7, "location_summary": "Tempe, Arizona • Miami, Florida • South Miami, Florida + 4 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04569786" }, { "nct_id": "NCT05738031", "title": "Investigating Incidental Pulmonary Nodules in Underserved Communities", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung; Node" ], "interventions": [], "intervention_types": [], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2023-10", "completion_date": "2025-05", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05738031" }, { "nct_id": "NCT00123435", "title": "Veterans Walk for Health Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Diseases", "Diabetes Mellitus", "Hyperlipidemia", "Hypertension", "Obesity" ], "interventions": [ { "name": "Nutritional counseling", "type": "BEHAVIORAL" }, { "name": "Walking program", "type": "BEHAVIORAL" }, { "name": "Simple pedometer", "type": "DEVICE" }, { "name": "Enhanced pedometer", "type": "DEVICE" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 254, "start_date": "2005-07", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2015-08-21", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00123435" }, { "nct_id": "NCT03873038", "title": "Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Dialysis", "Kidney Failure, Chronic" ], "interventions": [ { "name": "MK-2060", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 38, "start_date": "2019-04-29", "completion_date": "2021-12-20", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 3, "location_summary": "Orlando, Florida • Saint Paul, Minnesota • Knoxville, Tennessee", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03873038" }, { "nct_id": "NCT06503978", "title": "Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder", "Gastro-Intestinal Disorder", "Constipation", "Diarrhea" ], "interventions": [ { "name": "MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Vancomycin", "type": "COMBINATION_PRODUCT" }, { "name": "Miralax", "type": "COMBINATION_PRODUCT" }, { "name": "Antacid", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo MTP-101P", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo Vancomycin", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Gut-Brain-Axis Therapeutics Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Years to 18 Years" }, "enrollment_count": 60, "start_date": "2024-08-20", "completion_date": "2026-08-17", "has_results": false, "last_update_posted_date": "2024-09-25", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06503978" }, { "nct_id": "NCT03251482", "title": "A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery" ], "interventions": [ { "name": "JNJ-64179375 0.3 mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 0.6 mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 1.2 mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 (Dose to be Determined)", "type": "DRUG" }, { "name": "JNJ-64179375 A mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 B mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 C mg/kg", "type": "DRUG" }, { "name": "JNJ-64179375 D mg/kg", "type": "DRUG" }, { "name": "Placebo JNJ-64179375", "type": "DRUG" }, { "name": "Apixaban placebo", "type": "DRUG" }, { "name": "Apixaban 2.5 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 308, "start_date": "2017-11-13", "completion_date": "2018-11-05", "has_results": true, "last_update_posted_date": "2019-11-25", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 7, "location_summary": "Phoenix, Arizona • Torrance, California • Englewood, Colorado + 4 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Torrance", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "DeLand", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03251482" }, { "nct_id": "NCT03220724", "title": "Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "CH505TF", "type": "BIOLOGICAL" }, { "name": "CH505w53", "type": "BIOLOGICAL" }, { "name": "CH505w78", "type": "BIOLOGICAL" }, { "name": "CH505 M5", "type": "BIOLOGICAL" }, { "name": "GLA-SE adjuvant", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 117, "start_date": "2017-08-22", "completion_date": "2023-03-21", "has_results": true, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 8, "location_summary": "Birmingham, Alabama • San Francisco, California • Boston, Massachusetts + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03220724" }, { "nct_id": "NCT06508320", "title": "A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza", "SARS-CoV-2" ], "interventions": [ { "name": "mRNA-1083", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "50 Years to 64 Years" }, "enrollment_count": 932, "start_date": "2024-07-15", "completion_date": "2025-09-25", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 12, "location_summary": "Hialeah, Florida • Hollywood, Florida • Miami, Florida + 9 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" }, { "city": "River Forest", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06508320" }, { "nct_id": "NCT03119363", "title": "Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Myeloma", "Fatigue" ], "interventions": [ { "name": "AYO light glasses (Experimental)", "type": "DEVICE" }, { "name": "AYO light glasses (Comparator)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 194, "start_date": "2015-09-01", "completion_date": "2022-04-01", "has_results": false, "last_update_posted_date": "2022-06-16", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 3, "location_summary": "Hackensack, New Jersey • New York, New York", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03119363" }, { "nct_id": "NCT05940883", "title": "A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Y-2 Sublingual Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Simcere Pharmaceutical Co., Ltd", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 36, "start_date": "2023-09-06", "completion_date": "2023-12-05", "has_results": false, "last_update_posted_date": "2023-12-12", "last_synced_at": "2026-09-23T12:21:46.406Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05940883" } ] }